While multiple case reports and series have suggested that G-CSF can shorten the duration of neutropenia associated with non-chemotherapy medications, current evidence from prospective randomized studies has not demonstrated a significant clinical benefit [16]. This evidence concerns the gene CSF3 and Decreased total neutrophil count.